NON-PVC IV BAGS MARKET ANALYSIS

Three types of bags are commonly used for IV fluids, which include glass bottles, PVC bags, and non-PVC bags. Certain drugs such as some insulin preservatives, vitamins, and others can react with PVC bags. Non-PVC bags are similar to PVC bags, but they generally do not react, although it depends on the drug being used. They are convenient for handling and transportation. The non-PVC IV bags include polypropylene IV bags, polyethylene IV bags, ethylene-vinyl acetate (EVA) IV bags, copolyester ether IV bags, and others.

The global non-PVC IV bags market is estimated to be valued at US$ 1,805.6 million in 2021, and is expected to exhibit a CAGR of 9.5% during the forecast period (2021-2028).

Figure 1. Global Non-PVC IV Bags Market Share (%) in Terms of Value, by Type, 2021

To learn more about this report, request a free sample copy

Increasing prevalence of cancer is expected to drive the market growth during the forecast period.

Factors such as the rising prevalence of cancer are expected to drive the market growth during the forecast period, as chemotherapy involves administration of medications orally or through an intravenous (IV) route. For instance, according to the World Health Organization (WHO), cancer is the second leading cause of death in the world. The American Cancer Society estimated that over 1.7 million new cancer cases were diagnosed in the U.S. in 2019. Moreover, according to an article published by Cancer Research U.K., in March 2020, 367,000 new cancer cases are reported each year in the U.K.

Figure 2. Global Non-PVC IV Bags Market Share (%), by Material, 2021

To learn more about this report, request a free sample copy

Increasing product launches by the key players is expected to drive the market growth during the forecast period.

The increasing number of novel product launches by the key players is expected to drive the market growth during the forecast period. For instance, in April 2021, Fresenius Kabi, a global healthcare company, announced that it had introduced two new presentations of Heparin Sodium in ready-to-administer and convenient Freeflex IV bags in the U.S. Freeflex bags are made up of polyolefin, which are Di-ethylhexyl-phthalate (DEHP) plasticizer free and non PVC.

Global Non-PVC IV Bags Market– Impact of Coronavirus (COVID-19) Pandemic

Before COVID-19, the healthcare industry was shifting towards community wellness and population health while still economically dependent on expensive, invasive procedures, and treatments. Key players conducted their operations smoothly and were focused on implementing growth strategies such as product approval and acquisition in the global non-PVC IV bags market.

Due to COVID-19, lockdown or shutdown was imposed in several countries globally, which had a negative impact on the economy of the private healthcare sector globally. Furthermore, healthcare providers were facing challenges, in terms of additional manpower, equipment, consumables, and other resources, which are required to ensure safety in hospitals and provide treatment to patients with other diseases, and this has impacted the market negatively. Due to nationwide lockdowns, the supply chain was badly hampered. This caused problems in the transportation of non-PVC IV bags from one place to another.

Global Non-PVC IV Bags Market: Restraint

The major factor that hinder growth of the global non-PVC IV bags market include high cost of the non-PVC IV bags and stringent government regulatory policies.

Key Players

Major players operating in the global non-PVC IV bags market include Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.